Fmr LLC Arcutis Biotherapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 150,730 shares of ARQT stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

150,730

Previous 162,449 7.21%

Holding current value

$3.15 Million

Previous $2.54 Million 16.81%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$12.59 - $16.6 $147,542 - $194,535	-11,719 Reduced 7.21%	150,730 $2.11 Million
Q1 2025 May 12, 2025	SELL	$11.4 - $17.29 $252,054 - $382,281	-22,110 Reduced 11.98%	162,449 $2.54 Million
Q4 2024 Feb 13, 2025	BUY	$8.31 - $14.99 $110,855 - $199,966	13,340 Added 7.79%	184,559 $2.57 Million
Q3 2024 Nov 13, 2024	BUY	$8.32 - $11.0 $290,234 - $383,724	34,884 Added 25.59%	171,219 $1.59 Million
Q2 2024 Aug 13, 2024	SELL	$7.24 - $12.53 $34,484 - $59,680	-4,763 Reduced 3.38%	136,335 $1.27 Million
Q1 2024 May 13, 2024	SELL	$3.25 - $11.77 $3.51 Million - $12.7 Million	-1,081,306 Reduced 88.46%	141,098 $1.4 Million
Q4 2023 Feb 13, 2024	SELL	$1.84 - $4.82 $13 Million - $33.9 Million	-7,039,638 Reduced 85.2%	1,222,404 $3.95 Million
Q3 2023 Nov 13, 2023	SELL	$5.31 - $10.98 $5.05 Million - $10.4 Million	-950,744 Reduced 10.32%	8,262,042 $43.9 Million
Q2 2023 Aug 11, 2023	BUY	$7.51 - $15.0 $378,173 - $755,340	50,356 Added 0.55%	9,212,786 $87.8 Million
Q1 2023 May 11, 2023	BUY	$10.23 - $17.14 $237,919 - $398,624	23,257 Added 0.25%	9,162,430 $101 Million
Q4 2022 Feb 13, 2023	BUY	$13.96 - $20.4 $2.93 Million - $4.28 Million	209,942 Added 2.35%	9,139,173 $135 Million
Q3 2022 Nov 10, 2022	BUY	$17.85 - $26.95 $21.7 Million - $32.8 Million	1,216,551 Added 15.77%	8,929,231 $171 Million
Q2 2022 Aug 12, 2022	BUY	$16.33 - $22.2 $2.53 Million - $3.44 Million	155,087 Added 2.05%	7,712,680 $164 Million
Q1 2022 May 13, 2022	BUY	$14.38 - $22.79 $192,418 - $304,952	13,381 Added 0.18%	7,557,593 $146 Million
Q4 2021 Feb 14, 2022	BUY	$14.98 - $25.5 $119,046 - $202,648	7,947 Added 0.11%	7,544,212 $156 Million
Q3 2021 Nov 15, 2021	BUY	$19.28 - $27.1 $106,522 - $149,727	5,525 Added 0.07%	7,536,265 $180 Million
Q2 2021 Aug 13, 2021	BUY	$24.42 - $34.75 $184 Million - $262 Million	7,530,740 New	7,530,740 $206 Million

Others Institutions Holding ARQT

# of Institutions

242

Shares Held

131M

Call Options Held

407K

Put Options Held

216K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $1.26B
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account